CSL Behring AG drugs
3 results
Hizentra (human immunoglobulin g)
(HUMAN IMMUNOGLOBULIN G)CSL Behring AG
Usage: HIZENTRA is indicated for the treatment of primary immunodeficiency (PI) in patients aged 2 and older, including various humoral immune defects. It is also used as maintenance therapy for adults with chronic inflammatory demyelinating polyneuropathy (CIDP) to prevent relapse of neuromuscular disability.
Privigen (human immunoglobulin g)
(Human Immunoglobulin G)CSL Behring AG
Usage: PRIVIGEN is indicated for the treatment of primary humoral immunodeficiency, chronic immune thrombocytopenic purpura in patients aged 15 and older, and chronic inflammatory demyelinating polyneuropathy in adults to improve neuromuscular function. Maintenance therapy for CIDP has not been studied beyond six months.
Rhophylac (human rho(d) immune globulin)
(HUMAN RHO(D) IMMUNE GLOBULIN)CSL Behring AG
Usage: RHOPHYLAC is indicated for suppressing Rh isoimmunization in non-sensitized Rh(D)-negative patients during incompatible pregnancies and transfusions. It is also used to treat chronic immune thrombocytopenic purpura (ITP) in Rh(D)-positive adults to increase platelet counts.